Together Pharma Ltd
TGPHF · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $39,185 | $38,323 | $28,605 | $30,109 |
| - Cash | $7,583 | $7,583 | $3,592 | $3,592 |
| + Debt | $58,751 | $46,624 | $54,803 | $54,803 |
| Enterprise Value | $90,353 | $77,364 | $79,816 | $81,320 |
| Revenue | $25,201 | $25,201 | $22,743 | $22,743 |
| % Growth | 0% | 10.8% | 0% | – |
| Gross Profit | $9,581 | $9,581 | $8,757 | $8,757 |
| % Margin | 38% | 38% | 38.5% | 38.5% |
| EBITDA | $7,610 | $7,610 | $6,195 | $6,195 |
| % Margin | 30.2% | 30.2% | 27.2% | 27.2% |
| Net Income | $3,182 | $3,182 | -$4,461 | -$4,461 |
| % Margin | 12.6% | 12.6% | -19.6% | -19.6% |
| EPS Diluted | 0.25 | 0.25 | -0.51 | -0.51 |
| % Growth | 0% | 149% | 0% | – |
| Operating Cash Flow | $1,947 | $1,947 | $4,383 | $4,383 |
| Capital Expenditures | -$546 | -$546 | -$371 | -$371 |
| Free Cash Flow | $1,401 | $1,401 | $4,012 | $4,012 |